Home > About Nobivac > History of innovation

Strong bonds then. Even stronger bonds now.

Through MSD Animal Health, Nobivac has made significant contributions to the development and innovation of vaccines – enabling essential progress for animal health over the decades.

Year Innovation
1985 A live canine parvovirus vaccine: a revolution in canine vaccination. The first high titre, low passage vaccine against Canine Parvovirus (CPV) and the first to break through levels of maternally derived antibodies to allow puppies to complete their primary course vaccinations at 12 weeks of age.
1993 A live myxomatosis vaccine for rabbits: Myxomatosis is a real threat to pet rabbits. MSD AH developed the first fully authorised myxomatosis vaccine in the UK.
1999 A new trivalent live feline vaccine: first feline vaccine shown to cross-protect against canine parvovirus.
2000 An intranasal canine cough vaccine: the first bivalent intranasal vaccine against kennel cough in Ireland.
2002 Extended immunity: the world's first 2 year duration of immunity for CPV, CDV and CAV. Since the early 1990s the debate started as to whether annual vaccination was really necessary. Following extensive research we became the first to launch a vaccine with a proven extended duration of immunity.
2004 Canine cough vaccine: the first intranasal vaccine to provide a full one year protection against kennel cough. One month after the introduction of this claim, this vaccine became the leading vaccine in many countries.
2004 Extended immunity: the first vaccines against CDV, CAV and CPV with a proven 3 year duration of immunity. The claim was first launched in the UK, followed by USDA approval for the US in 2005.
2006 Proven cross-protection against CPV type 2c:
the first parvovirus vaccine with published evidence of complete protection against the newly-emerged CPV type 2c

Feline vaccine – extended immunity: providing a proven 3 year duration of immunity against panleucopenia.

2012 The first combined Myxomatosis / Rabbit Haemorrhagic disease vaccine for pet rabbits: the first RHD vaccine that is produced in tissue culture and not on live rabbits offering dual disease protection and 12 months duration of immunity from a single administration.
2013 Extended immunity to canine leptospirosis: the first tetravalent canine leptospirosis vaccine in Europe indicated to aid in the prevention of disease, mortality and urinary shedding caused by 4 serovars.
2013 New test methodology for animal welfare: MSD AH vaccines are the first canine leptospirosis vaccines that can be released using only in-vitro methods – i.e. without animal testing.

Canine Cough, or canine infectious tracheobronchitis, is a highly contagious respiratory disease in dogs. Found worldwide, the disease will affect a relatively high percentage of dogs in their lifetime. Learn how you can do your part to protect against Canine Cough and keep bonds strong.

  • Rabies causes over 55,000 deaths in people each year in Africa and India. Learn how you can help eliminate this deadly disease by protecting your pet with Nobivac vaccines.

  • Create stronger bonds by educating yourself on the importance of vaccinating your pets. Keep informed about the benefits of vaccination with our helpful animation.

  • Equine influenza is a highly infectious respiratory disease of horses. Found almost worldwide, the disease will affect a worrying percentage of horses in their lifetime. Learn how you can do your part to protect against Equine influenza and keep the bonds strong.